ライフサイエンスコーパス: cytokeratin-14

1 examined by immunohistochemistry for p63 and cytokeratin 14.

2 We show that formation of the actin/cytokeratin/14-3-3sigma complex and cellular migration a

3 owed thinning of skin epithelium and loss of cytokeratin 14, an early marker of skin differentiation.

4 mitant with known basal cell markers p63 and cytokeratin 14 and was high in the proliferative human p

5 umor cells expressing markers of basal (p63, cytokeratin 14) and luminal (cytokeratin 8 and androgen

6 uently stained for pimonidazole, sirius red, cytokeratin 14, and hematoxylin-eosin for quantitative a

7 eir morphology, trans-epithelial staining of cytokeratin 14, and suprabasalar proliferation.

8 actin, and gelsolin; increased staining for cytokeratin 14; and cell death.

9 Serial sections stained with cytokeratin 14 antibody confirmed the epithelial nature

10 ssion of androgen receptor, ERalpha, ERbeta, cytokeratin 14 (basal cells), cytokeratin 18 (luminal ce

11 re immunostained with antibodies to Muc1 and cytokeratin 14, both epithelial cell markers.

12 sitively for alpha-fetoprotein, albumin, and cytokeratin 14 (CK-14), protein markers expressed by the

13 pithelia that express nestin: one expressing cytokeratin 14 (CK14) and DeltaN-p63 and another express

14 d of stem cells, which were characterized by cytokeratin 14 (CK14) staining and enhanced tumor sphere

15 Cytokeratin 14 (CK14) was examined by immunohistochemist

16 responsible for metastatic events which are cytokeratin-14 (CK14) and E-cadherin positive in luminal

17 ferentiation during palate fusion, we bred a cytokeratin 14-Cre transgenic line into the R26R backgro

18 , cyclin D1, cyclin-dependent kinase 4, p53, cytokeratin 14, epidermal growth factor receptor, and by

19 that we now identify as a GSI-B(4) reactive, cytokeratin-14-expressing basal cell.

20 IHC confirmed increased cytokeratin 14 expression in female bladders and additio

21 dings and revealed a significant increase in cytokeratin 14 expression in the urothelium of the femal

22 20(OH)D3 stimulated involucrin and inhibited cytokeratin 14 expression.

23 tionship between loss of FOXA1 and increased cytokeratin 14 expression.

24 Co-localization studies with cytokeratin 14 indicated that KCNQ1 is also expressed in

25 Cytokeratin 14 is a biomarker in human esophageal carcin

26 binase (CreER(tam)) under the control of the cytokeratin 14 (K14) promoter (K14-CreER(tam)) and mice

27 t, the stratified squamous epithelial marker cytokeratin 14 (K14) was absent at the beginning, and ce

28 xpression of basal epithelial genes, such as cytokeratin-14 (K14) and p63.

29 n genes identified a 5-fold up-regulation of cytokeratin 14 mRNA expression in ZD:p53-/- versus ZS:p5

30 he GMp motif in the N-terminal region of the cytokeratin 14 of ameloblasts binds to trityrosyl motif

31 microtubules in mesenchymal cells increased cytokeratin 14-positive (K14+) progenitors and their dif

32 ders and additionally revealed enrichment of cytokeratin 14-positive basal cells in the hyperplastic